{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/89100711"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "product and associated risks, including the inherent difficulties and uncertainties in developing a drug compound such as obtaining FDA and other regulatory approvals; and risks related to the viability of and potential alternative treatments in any" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "financialcontent.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/331507217"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/89100711"] } } }
